Joseph Iii Klein - Net Worth and Insider Trading
Joseph Iii Klein Net Worth
The estimated net worth of Joseph Iii Klein is at least $3 Million dollars as of 2024-11-13. Joseph Iii Klein is the Director of Biomarin Pharmaceutical Inc and owns about 35,000 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $2 Million. Joseph Iii Klein is the Director of Ionis Pharmaceuticals Inc and owns about 16,446 shares of Ionis Pharmaceuticals Inc (IONS) stock worth over $621,165. Joseph Iii Klein is also the Director of PDL BioPharma Inc and owns about 16,983 shares of PDL BioPharma Inc (PDLI) stock worth over $41,948. Details can be seen in Joseph Iii Klein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Iii Klein has not made any transactions after 2024-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph Iii Klein
Joseph Iii Klein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Iii Klein owns 4 companies in total, including Ionis Pharmaceuticals Inc (IONS) , Akcea Therapeutics Inc (AKCA) , and Biomarin Pharmaceutical Inc (BMRN) among others .
Click here to see the complete history of Joseph Iii Klein’s form 4 insider trades.
Insider Ownership Summary of Joseph Iii Klein
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IONS | Ionis Pharmaceuticals Inc | 2024-07-16 | director |
AKCA | Akcea Therapeutics Inc | 2020-10-12 | director |
BMRN | Biomarin Pharmaceutical Inc | 2010-03-08 | director |
2009-11-04 | director |
Joseph Iii Klein Latest Holdings Summary
Joseph Iii Klein currently owns a total of 3 stocks. Among these stocks, Joseph Iii Klein owns 35,000 shares of Biomarin Pharmaceutical Inc (BMRN) as of March 8, 2010, with a value of $2 Million and a weighting of 77.73%. Joseph Iii Klein owns 16,446 shares of Ionis Pharmaceuticals Inc (IONS) as of July 16, 2024, with a value of $621,165 and a weighting of 20.86%. Joseph Iii Klein also owns 16,983 shares of PDL BioPharma Inc (PDLI) as of November 4, 2009, with a value of $41,948 and a weighting of 1.41%.
Latest Holdings of Joseph Iii Klein
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BMRN | Biomarin Pharmaceutical Inc | 2010-03-08 | 35,000 | 66.12 | 2,314,200 |
IONS | Ionis Pharmaceuticals Inc | 2024-07-16 | 16,446 | 37.77 | 621,165 |
PDLI | PDL BioPharma Inc | 2009-11-04 | 16,983 | 2.47 | 41,948 |
Holding Weightings of Joseph Iii Klein
Joseph Iii Klein Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Iii Klein has made a total of 0 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 10,000 shares on March 8, 2010, which brought Joseph Iii Klein around $221,200.
According to the SEC Form 4 filings, Joseph Iii Klein has made a total of 15 transactions in Ionis Pharmaceuticals Inc (IONS) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Ionis Pharmaceuticals Inc is the sale of 12,000 shares on July 16, 2024, which brought Joseph Iii Klein around $600,000.
According to the SEC Form 4 filings, Joseph Iii Klein has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the sale of 24,000 shares on November 4, 2009, which brought Joseph Iii Klein around $199,920.
Insider Trading History of Joseph Iii Klein
- 1
Joseph Iii Klein Trading Performance
GuruFocus tracks the stock performance after each of Joseph Iii Klein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Iii Klein is -11.8%. GuruFocus also compares Joseph Iii Klein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Iii Klein within 3 months outperforms 3 times out of 20 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph Iii Klein's insider trading performs compared to the benchmark.
Performance of Joseph Iii Klein
Joseph Iii Klein Ownership Network
Ownership Network List of Joseph Iii Klein
Ownership Network Relation of Joseph Iii Klein
Joseph Iii Klein Owned Company Details
What does Ionis Pharmaceuticals Inc do?
Who are the key executives at Ionis Pharmaceuticals Inc?
Joseph Iii Klein is the director of Ionis Pharmaceuticals Inc. Other key executives at Ionis Pharmaceuticals Inc include SVP & Research Eric Swayze , Senior Vice President Richard S Geary , and EVP & Corp and Development Ops Brian Birchler .
Ionis Pharmaceuticals Inc (IONS) Insider Trades Summary
Over the past 18 months, Joseph Iii Klein made 5 insider transaction in Ionis Pharmaceuticals Inc (IONS) with a net sale of 25,555. Other recent insider transactions involving Ionis Pharmaceuticals Inc (IONS) include a net sale of 181,397 shares made by Brett P Monia , a net sale of 35,600 shares made by Richard S Geary , and a net sale of 60,168 shares made by C Frank Bennett .
In summary, during the past 3 months, insiders sold 704 shares of Ionis Pharmaceuticals Inc (IONS) in total and bought 0 shares, with a net sale of 704 shares. During the past 18 months, 614,196 shares of Ionis Pharmaceuticals Inc (IONS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 614,196 shares.
Ionis Pharmaceuticals Inc (IONS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ionis Pharmaceuticals Inc Insider Transactions
Joseph Iii Klein Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Iii Klein. You might contact Joseph Iii Klein via mailing address: C/o Genaissance Pharmaceuticals Inc, Five Science Park, New Haven Ct 06511.